Junior Biotechs
Follow
Find
619 views | +0 today
Junior Biotechs
Investable trends in small cap biotechnology companies.
Curated by Jim Letourneau
Your new post is loading...
Your new post is loading...
Scooped by Jim Letourneau
Scoop.it!

Resverlogix Jumps as Data Show Plaque Improvement

Resverlogix Jumps as Data Show Plaque Improvement | Junior Biotechs | Scoop.it
Resverlogix Corp. climbed to its highest in almost two months after reporting some patients using its drug to fight thickening of the arteries had their plaque levels fall twice as much as targeted.
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

Biotechnology ETFs | ETF Trends

Biotechnology ETFs | ETF Trends | Junior Biotechs | Scoop.it
I do the “ETF of the Week” for MarketWatch every Thursday on Chuck Jaffe's MoneyLife Show where I highlight big movers and disappointments within the exchange traded fund market. This Thursday, I took a look at the ...
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

Biotech firm Randox hires specialist graduates - Irish Independent

Biotech firm Randox hires specialist graduates - Irish Independent | Junior Biotechs | Scoop.it
Biotech firm Randox hires specialist graduates Irish Independent "As a ground-breaking biotechnology company now employing over 1,200 people, we are revolutionising healthcare and diagnostics, competing and leading in high end industries around the...
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

City Surgeon: Can The Cleveland Clinic Save Its Hometown?

City Surgeon: Can The Cleveland Clinic Save Its Hometown? | Junior Biotechs | Scoop.it
Heart doctor turned CEO Delos Cosgrove has turned the Cleveland Clinic into one
of the world's great hospitals.
Is it good enough to resuscitate its hometown?
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

Biotech Stocks Continue to See Share Prices Jump on Catalysts - Minyanville.com

Biotech Stocks Continue to See Share Prices Jump on Catalysts - Minyanville.com | Junior Biotechs | Scoop.it
Biotech Stocks Continue to See Share Prices Jump on Catalysts
Minyanville.com
The past week has seen some enormous news within the biotechnology industry, and investors continue to see dramatic price swings in these exciting but risky biotech stocks.
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

Top Biotech States Ranked

Top Biotech States Ranked | Junior Biotechs | Scoop.it
A complex array of factors influence the allocation of resources and the nature of bioscience industry development. (Take a look at which states are leading the #biotechnology industry.
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

Pharma Continues To Seek External R&D Funding, This Time From The Government

Pharma Continues To Seek External R&D Funding, This Time From The Government | Junior Biotechs | Scoop.it
Now Pharma has found a new investor for its R&D efforts – the U.S. government.
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

News

New report confirms innovative pharmaceutical sector’s investment in Canada is chronically underreported - http://www.canadapharma.org/News.asp?a=view&id=61

more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

Lilly And Sanofi CEOs Take Two Very Different R&D Paths In Alzheimer's Disease - Forbes

Because of these challenges, last year I speculated that pharma companies might exit AD R&D. Last week, Sanofi’s CEO, Chris Viehbacher, did just that.
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

The Best- And Worst-Performing Biotech Stocks, April 5 To April 12 - Forbes

The Best- And Worst-Performing Biotech Stocks, April 5 To April 12 - Forbes | Junior Biotechs | Scoop.it
These are the best and worst-performing medical and biotech stocks from April 5 to April 12, 2013.
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

Natural soil bacteria pump new life into exhausted oil wells | Science Codex

Natural soil bacteria pump new life into exhausted oil wells | Science Codex | Junior Biotechs | Scoop.it
NEW ORLEANS, April 8, 2013 — Technology that enlists natural soil bacteria as 21st century roughnecks now is commercially available and poised to recover precious oil remaining in thousands of exhausted oil wells, according to a scientist who...
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

FDA working to speed up drug reviews despite federal budget cuts

FDA working to speed up drug reviews despite federal budget cuts | Junior Biotechs | Scoop.it
Boston Globe
FDA working to speed up drug reviews despite federal budget cuts ...
Boston Globe
... to Massachusetts Biotechnology Council executives, said. David L. Ryan/Globe staff.
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

Biotech Companies Maneuver To Limit Generics

Biotech Companies Maneuver To Limit Generics | Junior Biotechs | Scoop.it
Biotech Companies Maneuver To Limit Generics
Health Aim
Some of the nation's biggest biotechnology companies are lobbying intensively in statehouses around the country to limit generic competition to their blockbuster drugs.
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

Esperion's Novel Approach To Lowering Cholesterol - Will It Be Successful?

Esperion's Novel Approach To Lowering Cholesterol - Will It Be Successful? | Junior Biotechs | Scoop.it
Such challenges are things that companies didn’t have to face a decade ago. An exciting, truly novel drug would readily get tried by physicians, and payers would cover the added costs.
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

Agricultural biotech startup AgBiome gears up

Agricultural biotech startup AgBiome gears up | Junior Biotechs | Scoop.it
Agricultural biotech startup AgBiome gears up
Durham Herald Sun
The agricultural biotechnology company is new, gearing up this year after closing on $14.5 million in startup financing.
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

Biotech Sector Hits All-Time High! Here’s What You Need to Know

Biotech Sector Hits All-Time High! Here’s What You Need to Know | Junior Biotechs | Scoop.it
Biotech Sector Hits All-Time High!Here’s What You Need to Know (Investing in biotechnology led to a 46% return: http://t.co/QHrw0MYIjk Investing in religion leads to a 0% return.)...
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

Pulse of the Canadian healthcare sector (Part 3): improving the funding for early stage companies

Pulse of the Canadian healthcare sector (Part 3): improving the funding for early stage companies | Junior Biotechs | Scoop.it
Based on personal discussions and CVCA financing data (see Part 2 of this blog series), I conclude there has been insufficient funding available for the quality early stage Canadian healthcare companies and technologies for several years.
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

ImClone's Waksal Back in Biotech With Plans for Spinouts - Bloomberg

ImClone's Waksal Back in Biotech With Plans for Spinouts - Bloomberg | Junior Biotechs | Scoop.it
ImClone's Waksal Back in Biotech With Plans for Spinouts Bloomberg (LLY) for $6.5 billion, and four years after he served jail time in an insider trading scandal that ensnared Martha Stewart, Waksal is again making moves in the biotechnology...
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

FDA Commissioner Hints At New Diagnostic Test Regulations

FDA Commissioner Hints At New Diagnostic Test Regulations | Junior Biotechs | Scoop.it
The Food and Drug Administration will take new steps to enforce regulations against certain kinds of diagnostic tests, including some used for personalized medicine, to which it previously took a laissez-faire attitude.
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

Biotech industry faces funding crunch, report says

Biotech industry faces funding crunch, report says | Junior Biotechs | Scoop.it
Wall Street Journal (blog) Biotech industry faces funding crunch, report says National Post In 2012, revenues across established biotechnology centres — the U.S., Canada, Europe and Australia — revenues rose 8% to US$89.8-billion and net income...
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

Small Companies Are Leading Innovation For New Drugs To Treat Depression

Yet, the medical need in a disease like depression remains high. Existing drugs are effective in only half of patients with depression. Furthermore, these drugs can take 3 – 4 weeks before their beneficial effects are manifest.
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

Science-Based Medicine » Uneasy Lies the Head That Wears the Flu

Infectious diseases (ID), as those who read my not-so-secret other blog know, is without a doubt the most interesting speciality of medicine. Every interesting...
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

What Does This $14 Billion Deal Mean For The Future Of DNA Sequencing?

In a deal that could have a big impact on the future of DNA sequencing technology, lab equipment Thermo Fisher Scientific is buying rival Life Technologies for $13.6 billion in cash and the assumption of $2.2 billion in debt.
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

Local biotech inventor gets $95M verdict in patent suit - The Seattle Times

Local biotech inventor gets $95M verdict in patent suit - The Seattle Times | Junior Biotechs | Scoop.it
Local biotech inventor gets $95M verdict in patent suit
The Seattle Times
A small Auburn biotechnology company has won what may be the biggest patent-infringement verdict in state history, though the $95.8 million judgment likely will be appealed.
more...
No comment yet.
Scooped by Jim Letourneau
Scoop.it!

Monday Deal Review: March 18, 2013

Monday Deal Review: March 18, 2013 | Junior Biotechs | Scoop.it
Welcome to your Monday Biotech Deal Review for March 18, 2013! Another busy week on the investment front saw a number of financings close as well as details provided for ongoing private placements.
more...
No comment yet.